Citations (157)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (23)
Reza Elahi, Salar Hozhabri, Amirhosein Moradi, Amir Siahmansouri, Armin Jahani Maleki & Abdolreza Esmaeilzadeh. (2023) Targeting the cGAS-STING pathway as an inflammatory crossroad in coronavirus disease 2019 (COVID-19). Immunopharmacology and Immunotoxicology 45:6, pages 639-649.
Read now
Read now
Roghayeh Mohammadzadeh, Saman Soleimanpour, Abbas Pishdadian & Hadi Farsiani. (2022) Designing and development of epitope-based vaccines against Helicobacter pylori. Critical Reviews in Microbiology 48:4, pages 489-512.
Read now
Read now
Chen Han, Cong Zhang, Hengxiao Wang & Lianmei Zhao. (2021) Exosome-mediated communication between tumor cells and tumor-associated macrophages: implications for tumor microenvironment. OncoImmunology 10:1.
Read now
Read now
Rinku Sharma, Arivukarasu Palanisamy, Kuldeep Dhama, Gorakh Mal, Birbal Singh & Karam Pal Singh. (2020) Exploring the possible use of saponin adjuvants in COVID-19 vaccine. Human Vaccines & Immunotherapeutics 16:12, pages 2944-2953.
Read now
Read now
Rajnish Sahu, Richa Verma, Saurabh Dixit, Joseph U. Igietseme, Carolyn M Black, Skyla Duncan, Shree R Singh & Vida A Dennis. (2018) Future of human Chlamydia vaccine: potential of self-adjuvanting biodegradable nanoparticles as safe vaccine delivery vehicles. Expert Review of Vaccines 17:3, pages 217-227.
Read now
Read now
Lisa D. MacDonald, Alecia MacKay, Valarmathy Kaliaperumal, Genevieve Weir, Andrea Penwell, Rajkannan Rajagopalan, Joanne M. Langley, Scott Halperin, Marc Mansour & Marianne M. Stanford. (2018) Type III hypersensitivity reactions to a B cell epitope antigen are abrogated using a depot forming vaccine platform. Human Vaccines & Immunotherapeutics 14:1, pages 59-66.
Read now
Read now
Yahua Lin, Xin Wang, Xiaofen Huang, Jun Zhang, Ningshao Xia & Qinjian Zhao. (2017) Calcium phosphate nanoparticles as a new generation vaccine adjuvant. Expert Review of Vaccines 16:9, pages 895-906.
Read now
Read now
Imran Shahid, Waleed Hassan ALMalki, Muhammad Hassan Hafeez & Sajida Hassan. (2016) Hepatitis C virus infection treatment: An era of game changer direct acting antivirals and novel treatment strategies. Critical Reviews in Microbiology 42:4, pages 535-547.
Read now
Read now
Daniel O Villarreal, Rebekah J Siefert & David B Weiner. (2015) Alarmin IL-33 elicits potent TB-specific cell-mediated responses. Human Vaccines & Immunotherapeutics 11:8, pages 1954-1960.
Read now
Read now
Fernanda Tavares Da Silva, Alberta Di Pasquale, Juan P Yarzabal & Nathalie Garçon. (2015) Safety assessment of adjuvanted vaccines: Methodological considerations. Human Vaccines & Immunotherapeutics 11:7, pages 1814-1824.
Read now
Read now
Karen AO Martins, Sina Bavari & Andres M Salazar. (2015) Vaccine adjuvant uses of poly-IC and derivatives. Expert Review of Vaccines 14:3, pages 447-459.
Read now
Read now
Annette M Dougall & Annette M Dougall. (2014) Lipid core peptide targeting the cathepsin D hemoglobinase of Schistosoma mansoni as a component of a schistosomiasis vaccine. Human Vaccines & Immunotherapeutics 10:2, pages 399-409.
Read now
Read now
Torben Knuschke, Matthias Epple & Astrid M Westendorf. (2014) The type of adjuvant strongly influences the T-cell response during nanoparticle-based immunization. Human Vaccines & Immunotherapeutics 10:1, pages 164-169.
Read now
Read now
Robert O Dillman. (2013) Melanoma vaccines: trials and tribulations. Vaccine: Development and Therapy 3, pages 57-78.
Read now
Read now
Orli Even-Or, Sarit Samira, Ronald Ellis, Eli Kedar & Yechezkel Barenholz. (2013) Adjuvanted influenza vaccines. Expert Review of Vaccines 12:9, pages 1095-1108.
Read now
Read now
David A Reardon, Kai W Wucherpfennig, Gordon Freeman, Catherine J Wu, E Antonio Chiocca, Patrick Y Wen, William T Curry$suffix/text()$suffix/text(), Duane A Mitchell, Peter E Fecci, John H Sampson & Glenn Dranoff. (2013) An update on vaccine therapy and other immunotherapeutic approaches for glioblastoma. Expert Review of Vaccines 12:6, pages 597-615.
Read now
Read now
Jessica C. Dong & Gary P. Kobinger. (2013) Hypothesis driven development of new adjuvants. Human Vaccines & Immunotherapeutics 9:4, pages 808-811.
Read now
Read now
Ana Isabel Camacho, Juan Manuel Irache & Carlos Gamazo. (2013) Recent progress towards development of a Shigella vaccine. Expert Review of Vaccines 12:1, pages 43-55.
Read now
Read now
Andres H. Gutiérrez, Denice Spero, Cyril Gay, Mirko Zimic & Anne S. De Groot. (2012) New vaccines needed for pathogens infecting animals and humans. Human Vaccines & Immunotherapeutics 8:7, pages 971-978.
Read now
Read now
Apostolis Stathopoulos, Chrystel Pretto, Laurent Devillers, Denis Pierre, Florence M. Hofman, Carol Kruse, Martin Jadus, Thomas C. Chen & Virgil E.J.C. Schijns. (2012) Development of immune memory to glial brain tumors after tumor regression induced by immunotherapeutic Toll-like receptor 7/8 activation. OncoImmunology 1:3, pages 298-305.
Read now
Read now
Ching-Liang Chu, Dz-Chi Chen & Chi-Chen Lin. (2011) A novel adjuvant Ling Zhi-8 for cancer DNA vaccines. Human Vaccines 7:11, pages 1161-1164.
Read now
Read now
Joseph U Igietseme, Francis O Eko & Carolyn M Black. (2011) Chlamydia vaccines: recent developments and the role of adjuvants in future formulations. Expert Review of Vaccines 10:11, pages 1585-1596.
Read now
Read now
Erika Jensen-Jarolim & Josef Singer. (2011) Cancer vaccines inducing antibody production: more pros than cons. Expert Review of Vaccines 10:9, pages 1281-1289.
Read now
Read now
Articles from other publishers (134)
Peter Van der Ley & Virgil EJC Schijns. (2023) Outer membrane vesicle-based intranasal vaccines. Current Opinion in Immunology 84, pages 102376.
Crossref
Crossref
Alessio Malfanti, Mathilde Bausart, Kevin Vanvarenberg, Bernard Ucakar & Véronique Préat. (2023) Hyaluronic acid-antigens conjugates trigger potent immune response in both prophylactic and therapeutic immunization in a melanoma model. Drug Delivery and Translational Research 13:10, pages 2550-2567.
Crossref
Crossref
Li Zhuang, Zhaoyang Ye, Linsheng Li, Ling Yang & Wenping Gong. (2023) Next-Generation TB Vaccines: Progress, Challenges, and Prospects. Vaccines 11:8, pages 1304.
Crossref
Crossref
Chu-Xin Li, Yongdan Qi, Yingge Chen, Yu Zhang, Bin Li, Jun Feng & Xian-Zheng Zhang. (2023) Tuning Bacterial Morphology to Enhance Anticancer Vaccination. ACS Nano 17:9, pages 8815-8828.
Crossref
Crossref
Flora Carnet, Laure Perrin-Cocon, Romain Paillot, Vincent Lotteau, Stéphane Pronost & Pierre-Olivier Vidalain. (2023) An inventory of adjuvants used for vaccination in horses: the past, the present and the future. Veterinary Research 54:1.
Crossref
Crossref
Ebtisam A. Aldaais. (2022) A comprehensive review on the COVID-19 vaccine and drug delivery applications of interpenetrating polymer networks. Drug Delivery and Translational Research 13:3, pages 738-756.
Crossref
Crossref
Doaa E. Said, Eglal I. Amer, Eman Sheta, Shaimaa Makled, Fadwa M. Arafa & Hala E. Diab. (2023) Nano-Encapsulated Antioxidant: Retinoic Acid as a Natural Mucosal Adjuvant for Intranasal Immunization against Chronic Experimental Toxoplasmosis. Tropical Medicine and Infectious Disease 8:2, pages 106.
Crossref
Crossref
Roza Shamilevna Zayneeva, Aygul' Kamilovna Gil'mutdinova, Igor' Olegovich Zolotovskiy, Anna Vyacheslavovna Khokhlova, Valeriya Aleksandrovna Ribenek & Tat'yana Petrovna Gening. (2022) LASER ADJUVANTS: KEY FEATURES AND SPECIFICITY. Ulyanovsk Medico-biological Journal:4, pages 93-108.
Crossref
Crossref
Morgan Marriott, Brittany Post & Lipika Chablani. (2022) A Comparison of Cancer Vaccine Adjuvants in Clinical Trials. Cancer Treatment and Research Communications, pages 100667.
Crossref
Crossref
Doaa E. Said, Eglal I. Amer, Eman Sheta, Shaimaa Makled, Hala E. Diab & Fadwa M. Arafa. (2022) Nano-Encapsulated Melatonin: A Promising Mucosal Adjuvant in Intranasal Immunization against Chronic Experimental T. gondii Infection. Tropical Medicine and Infectious Disease 7:12, pages 401.
Crossref
Crossref
Selin Parmaksız, Aytül Gül, Sedef Erkunt Alak, Muhammet Karakavuk, Hüseyin Can, Ceren Gül, Tuğba Karakavuk, Constantino López-Macías, Nuhan Puralı, Mert Döşkaya & Sevda Şenel. (2022) Development of multistage recombinant protein vaccine formulations against toxoplasmosis using a new chitosan and porin based adjuvant system. International Journal of Pharmaceutics 626, pages 122199.
Crossref
Crossref
Dinesh Kumar Chellappan, Richie R. Bhandare, Afzal B. Shaik, Krishna Prasad, Nurfatihah Azlyna Ahmad Suhaimi, Wei Sheng Yap, Arpita Das, Pradipta Banerjee, Nandini Ghosh, Tanner Guith, Amitava Das, Sarannya Balakrishnan, Mayuren Candasamy, Jayashree Mayuren, Kishneth Palaniveloo, Gaurav Gupta, Sachin Kumar Singh & Kamal Dua. (2022) Vaccine for Diabetes—Where Do We Stand?. International Journal of Molecular Sciences 23:16, pages 9470.
Crossref
Crossref
Dominic Augustine, C. Pushpalatha, S.V. Sowmya, Chhaya Kumar, Elizabeth Abbu Varghese & V.S. Gayathri. 2022. Nanovaccinology as Targeted Therapeutics. Nanovaccinology as Targeted Therapeutics
301
318
.
Priyal Bagwe, Lotika Bajaj, Rikhav P. Gala, Martin J. D‘Souza & Susu M. Zughaier. (2022) Assessment of In Vitro Immunostimulatory Activity of an Adjuvanted Whole-Cell Inactivated Neisseria gonorrhoeae Microparticle Vaccine Formulation. Vaccines 10:7, pages 983.
Crossref
Crossref
Ling Mao, Chang Liu, Jing-Yi Liu, Zi-Li Jin, Zhe Jin, Ruo-Yi Xue, Rang Feng, Guo-Cheng Li, Yan Deng, Hao Cheng, Quan-Ming Zou & Hai-Bo Li. (2022) Novel Synthetic Lipopeptides as Potential Mucosal Adjuvants Enhanced SARS-CoV-2 rRBD-Induced Immune Response. Frontiers in Immunology 13.
Crossref
Crossref
Rushit N. Lodaya, Sonia Gregory, Mansoor M. Amiji & Derek T. O'Hagan. 2022. Practical Aspects of Vaccine Development. Practical Aspects of Vaccine Development
9
25
.
Tuyelee Das, Mimosa Ghorai, Uttpal Anand, Arabinda Ghosh, Potshangbam Nongdam, Mahipal S. Shekhawat, Devendra Kumar Pandey & Abhijit Dey. 2022. Nano-Strategies for Addressing Antimicrobial Resistance. Nano-Strategies for Addressing Antimicrobial Resistance
183
192
.
Farrhana Ziana Firdaus, Mariusz Skwarczynski & Istvan Toth. 2022. Vaccine Design. Vaccine Design
145
178
.
Qiao Li, Zhihua Liu, Yi Liu, Chen Liang, Jiayi Shu, Xia Jin, Chuanyou Li & Zhihua Kou. (2021) A Combined Adjuvant TF–Al Consisting of TFPR1 and Aluminum Hydroxide Augments Strong Humoral and Cellular Immune Responses in Both C57BL/6 and BALB/c Mice. Vaccines 9:12, pages 1408.
Crossref
Crossref
Yucheol Cheong, Minjin Kim, Jina Ahn, Hana Oh, Jongkwan Lim, Wonil Chae, Seung Won Yang, Min Seok Kim, Ji Eun Yu, Sanguine Byun, Yo Han Jang & Baik Lin Seong. (2021) Epigallocatechin-3-Gallate as a Novel Vaccine Adjuvant. Frontiers in Immunology 12.
Crossref
Crossref
Yohei Maki, Satoshi Kashiwagi & Yoshifumi Kimizuka. (2021) Laser vaccine adjuvants: Light-augmented immune responses. Vaccine 39:46, pages 6805-6812.
Crossref
Crossref
Sakineh Pirahmadi, Shima Afzali, Mostafa Zargar, Sedigheh Zakeri & Akram Abouie Mehrizi. (2021) How can we develop an effective subunit vaccine to achieve successful malaria eradication?. Microbial Pathogenesis 160, pages 105203.
Crossref
Crossref
Chaojie Xu, Ronge Xing, Song Liu, Yukun Qin, Kecheng Li, Huahua Yu & Pengcheng Li. (2021) Loading Effect of Chitosan Derivative Nanoparticles on Different Antigens and Their Immunomodulatory Activity on Dendritic Cells. Marine Drugs 19:10, pages 536.
Crossref
Crossref
Cong Sun, Xin-chun Chen, Yin-feng Kang & Mu-sheng Zeng. (2021) The Status and Prospects of Epstein–Barr Virus Prophylactic Vaccine Development. Frontiers in Immunology 12.
Crossref
Crossref
Xuan Lin, Zhiguo Su, Yanli Yang & Songping Zhang. (2021) The potential of ionic liquids in biopharmaceutical engineering. Chinese Journal of Chemical Engineering 30, pages 236-243.
Crossref
Crossref
Diksha Gupta, Aishwarya Gangwar, Kiran Jyoti, Vaskuri G.S. Sainaga Jyothi, Rupinder Kaur Sodhi, Neelesh Kumar Mehra, Shashi Bala Singh & Jitender Madan. (2020) Self healing hydrogels: A new paradigm immunoadjuvant for delivering peptide vaccine. Colloids and Surfaces B: Biointerfaces 194, pages 111171.
Crossref
Crossref
Adriana Magalhães Santos Andresen, Pierre Boudinot & Tor Gjøen. (2020) Kinetics of transcriptional response against poly (I:C) and infectious salmon anemia virus (ISAV) in Atlantic salmon kidney (ASK) cell line. Developmental & Comparative Immunology 110, pages 103716.
Crossref
Crossref
Archana Madhav, Tanshi Mehrotra, Pallavi Sinha & Ankur Mutreja. (2020) Vaccines for neglected, emerging and re-emerging diseases. Seminars in Immunology 50, pages 101423.
Crossref
Crossref
Camila Marques-da-Silva, Kristen Peissig & Samarchith P. Kurup. (2020) Pre-Erythrocytic Vaccines against Malaria. Vaccines 8:3, pages 400.
Crossref
Crossref
Virgil Schijns & Ed C. Lavelle. (2020) Prevention and treatment of COVID‐19 disease by controlled modulation of innate immunity. European Journal of Immunology 50:7, pages 932-938.
Crossref
Crossref
Satoshi Kashiwagi. (2020) Laser adjuvant for vaccination. The FASEB Journal 34:3, pages 3485-3500.
Crossref
Crossref
Rowena Silcock, Nigel W Crawford, Gowri Selvaraj, Alissa McMinn, Margie Danchin, Teresa Lazzaro & Kirsten P Perrett. (2020) Subcutaneous nodules following immunization in children; in Victoria, Australia from 2007 to 2016. Vaccine 38:15, pages 3169-3177.
Crossref
Crossref
Yu-Chao Zhu, Yong He, Jian-Fa Liu & Jia Chen. (2020)
Adjuvantic cytokine IL-33 improves the protective immunity of cocktailed DNA vaccine of ROP5 and ROP18 against
toxoplasma gondii
infection in mice
. Parasite 27, pages 26.
Crossref
Crossref
Sakineh Pirahmadi, Sedigheh Zakeri, Akram A. Mehrizi, Navid D. Djadid, Abbas-Ali Raz, Jafar J. Sani, Ronak Abbasi & Zahra Ghorbanzadeh. (2019) Cell-traversal protein for ookinetes and sporozoites (CelTOS) formulated with potent TLR adjuvants induces high-affinity antibodies that inhibit Plasmodium falciparum infection in Anopheles stephensi. Malaria Journal 18:1.
Crossref
Crossref
Rushit N. Lodaya, Amey P. Kanitkar, Kristian Friedrich, Dawn Henson, Ryan Yamagata, Sandra Nuti, Corey P. Mallett, Sylvie Bertholet, Mansoor M. Amiji & Derek T. O’Hagan. (2019) Formulation Design, Optimization and In Vivo Evaluations of an α-Tocopherol-Containing Self-Emulsified Adjuvant System using Inactivated Influenza Vaccine. Journal of Controlled Release 316, pages 12-21.
Crossref
Crossref
Kacy S. Yount, Jamie Jennings-Gee, Kyle Caution, Audra R. Fullen, Kara N. Corps, Sally Quataert, Rajendar Deora & Purnima Dubey. (2019)
Bordetella
Colonization Factor A (BcfA) Elicits Protective Immunity against Bordetella bronchiseptica in the Absence of an Additional Adjuvant
. Infection and Immunity 87:10.
Crossref
Crossref
Jin Zhang, Ninghua Liu, Yang Lu, Zhen Huang, Yuhui Zang, Jiangning Chen, Junfeng Zhang & Zhi Ding. (2019) Phosphorothioated antisense oligodeoxynucleotide suppressing interleukin-10 is a safe and potent vaccine adjuvant. Vaccine 37:30, pages 4081-4088.
Crossref
Crossref
Sakineh Pirahmadi, Sedigheh Zakeri, Akram A. Mehrizi, Navid D. Djadid, Abbas-Ali Raz & Jafar J. Sani. (2019) Combining Monophosphoryl Lipid A (MPL), CpG Oligodeoxynucleotide (ODN), and QS-21 Adjuvants Induces Strong and Persistent Functional Antibodies and T Cell Responses against Cell-Traversal Protein for Ookinetes and Sporozoites (CelTOS) of Plasmodium falciparum in BALB/c Mice. Infection and Immunity 87:6.
Crossref
Crossref
Hussein Masoud. (2019) Novel adjuvants derived from attenuated lipopolysaccharides and lipid As of purple non-sulfur photosynthetic bacteria. Vaccine 37:26, pages 3472-3477.
Crossref
Crossref
José M. Jiménez, Michelle L. Salazar, Sergio Arancibia, Javiera Villar, Fabián Salazar, Gordon D. Brown, Ed C. Lavelle, Luisa Martínez-Pomares, Jafet Ortiz-Quintero, Sergio Lavandero, Augusto Manubens & María Inés Becker. (2019) TLR4, but Neither Dectin-1 nor Dectin-2, Participates in the Mollusk Hemocyanin-Induced Proinflammatory Effects in Antigen-Presenting Cells From Mammals. Frontiers in Immunology 10.
Crossref
Crossref
Reshma J. Nevagi, Mariusz Skwarczynski & Istvan Toth. (2019) Polymers for subunit vaccine delivery. European Polymer Journal 114, pages 397-410.
Crossref
Crossref
Olusegun Ikusika, Conference Mpendulo, Titus Zindove & Anthony Okoh. (2019) Fossil Shell Flour in Livestock Production: A Review. Animals 9:3, pages 70.
Crossref
Crossref
Dulce Bento, Sandra Jesus, Filipa Lebre, Teresa Gonçalves & Olga Borges. (2019) Chitosan Plus Compound 48/80: Formulation and Preliminary Evaluation as a Hepatitis B Vaccine Adjuvant. Pharmaceutics 11:2, pages 72.
Crossref
Crossref
Saeedeh Rastakhiz, Mona Yazdani, Sheida Shariat, Atefeh Arab, Amir Abbas Momtazi‐Borojeni, Nastaran Barati, Mercedeh Mansourian, Mohamdreza Amin, Azam Abbasi, Zahra Saberi, Seyed Amir Jalali, Ali Badiee & Mahmoud Reza Jaafari. (2018) Preparation of nanoliposomes linked to HER2/neu‐derived (P5) peptide containing MPL adjuvant as vaccine against breast cancer. Journal of Cellular Biochemistry 120:2, pages 1294-1303.
Crossref
Crossref
Xiaochen Guo, Qi Zheng, Xinghao Jiang, Chao Wu, Teng Zhang, Dan Wang, Xiangxiang Wang, Tianyan Liu, Nan Wang, Yiyao Jiang, Deshan Li & Guiping Ren. (2019) The composite biological adjuvants enhance immune response of porcine circovirus type2 vaccine. Veterinary Microbiology 228, pages 69-76.
Crossref
Crossref
F. Lebre, M.C. Pedroso de Lima, Ed C. Lavelle & O. Borges. (2018) Mechanistic study of the adjuvant effect of chitosan-aluminum nanoparticles. International Journal of Pharmaceutics 552:1-2, pages 7-15.
Crossref
Crossref
Tomoya Hayashi, Masatoshi Momota, Etsushi Kuroda, Takato Kusakabe, Shingo Kobari, Kotaro Makisaka, Yoshitaka Ohno, Yusuke Suzuki, Fumika Nakagawa, Michelle S. J. Lee, Cevayir Coban, Risako Onodera, Taishi Higashi, Keiichi Motoyama, Ken J. Ishii & Hidetoshi Arima. (2018) DAMP-Inducing Adjuvant and PAMP Adjuvants Parallelly Enhance Protective Type-2 and Type-1 Immune Responses to Influenza Split Vaccination. Frontiers in Immunology 9.
Crossref
Crossref
Utpal Kumar Adhikari, Mourad Tayebi & M. Mizanur Rahman. (2018) Immunoinformatics Approach for Epitope-Based Peptide Vaccine Design and Active Site Prediction against Polyprotein of Emerging Oropouche Virus. Journal of Immunology Research 2018, pages 1-22.
Crossref
Crossref
Natalia Muñoz‐Wolf & Ed C. Lavelle. (2018)
A Guide to
IL
‐1 family cytokines in adjuvanticity
. The FEBS Journal 285:13, pages 2377-2401.
Crossref
Crossref
Kevin Brown, Montserrat Puig, Lydia Haile, Derek Ireland, John Martucci & Daniela Verthelyi. 2018. Oligonucleotide‐Based Drugs and Therapeutics. Oligonucleotide‐Based Drugs and Therapeutics
411
444
.
Sonia Jain, Parakkal Jovvian George, Wanyan Deng, Joseph Koussa, Kaela Parkhouse, Scott E. Hensley, Jiu Jiang, Jie Lu, Zhuyun Liu, Junfei Wei, Bin Zhan, Maria Elena Bottazzi, Hao Shen & Sara Lustigman. (2018) The parasite-derived rOv-ASP-1 is an effective antigen-sparing CD4 + T cell-dependent adjuvant for the trivalent inactivated influenza vaccine, and functions in the absence of MyD88 pathway. Vaccine 36:25, pages 3650-3665.
Crossref
Crossref
Yoshimi Fukushima, Masaaki Okamoto, Kana Ishikawa, Takahisa Kouwaki, Hirotake Tsukamoto & Hiroyuki Oshiumi. (2018) Activation of TLR3 and its adaptor TICAM-1 increases miR-21 levels in extracellular vesicles released from human cells. Biochemical and Biophysical Research Communications 500:3, pages 744-750.
Crossref
Crossref
Kuang Tan, Ruizhen Li, Xiaotian Huang & Qiong Liu. (2018) Outer Membrane Vesicles: Current Status and Future Direction of These Novel Vaccine Adjuvants. Frontiers in Microbiology 9.
Crossref
Crossref
Annalisa Ciabattini, Elena Pettini, Fabio Fiorino, Simone Lucchesi, Gabiria Pastore, Jlenia Brunetti, Francesco Santoro, Peter Andersen, Luisa Bracci, Gianni Pozzi & Donata Medaglini. (2018) Heterologous Prime-Boost Combinations Highlight the Crucial Role of Adjuvant in Priming the Immune System. Frontiers in Immunology 9.
Crossref
Crossref
Alexander Batista-Duharte, Damiana Téllez-Martínez, Deivys Leandro Portuondo Fuentes & Iracilda Zeppone Carlos. (2018) Molecular adjuvants that modulate regulatory T cell function in vaccination: A critical appraisal. Pharmacological Research 129, pages 237-250.
Crossref
Crossref
Rakesh Bastola, Gyubin Noh, Taekwang Keum, Santosh Bashyal, Jo-Eun Seo, Jaewoong Choi, Yeonsu Oh, YoungSik Cho & Sangkil Lee. (2017) Vaccine adjuvants: smart components to boost the immune system. Archives of Pharmacal Research 40:11, pages 1238-1248.
Crossref
Crossref
Bin Li, Hanmei Yuan, Li Chen, Heqiang Sun, Jian Hu, Shanshan Wei, Zhuo Zhao, Quanming Zou & Chao Wu. (2017)
The influence of adjuvant on UreB protection against
Helicobacter pylori
through the diversity of CD4+ T-cell epitope repertoire
. Oncotarget 8:40, pages 68138-68152.
Crossref
Crossref
M.R. Cambronero, D. Prado-Cohrs & M. Lopez Sanroma. (2017) Basic immunological concepts applied to vaccination. Vacunas (English Edition) 18:2, pages 49-58.
Crossref
Crossref
M.R. Cambronero, D. Prado-Cohrs & M. Lopez Sanroma. (2017) Conceptos inmunológicos básicos aplicados a la vacunología. Vacunas 18:2, pages 49-58.
Crossref
Crossref
F. Lebre, D. Bento, J. Ribeiro, M. Colaço, G. Borchard, M.C. Pedroso de Lima & O. Borges. (2017) Association of chitosan and aluminium as a new adjuvant strategy for improved vaccination. International Journal of Pharmaceutics 527:1-2, pages 103-114.
Crossref
Crossref
Chung‐Da Yang. 2017. Toxoplasmosis. Toxoplasmosis.
A. Nazmi, R. Hauck, A. Davis, M. Hildebrand, L.B. Corbeil & R.A. Gallardo. (2017) Diatoms and diatomaceous earth as novel poultry vaccine adjuvants. Poultry Science 96:2, pages 288-294.
Crossref
Crossref
M.M. Strioga & N.T. Dobrovolskiene. 2017. Immunopotentiators in Modern Vaccines. Immunopotentiators in Modern Vaccines
43
64
.
Manish Gautam, Bhushan Patwardhan, Sunil Gairola & Suresh Jadhav. 2017. Innovative Approaches in Drug Discovery. Innovative Approaches in Drug Discovery
315
341
.
Cristina Maria de Barros, Emad Ibrahim Wafa, Khanidtha Chitphet, Kawther Ahmed, Sean M. Geary & Aliasger K. Salem. 2017. Vaccine Adjuvants. Vaccine Adjuvants
201
213
.
Ruchi R. Shah, Kimberly J. Hassett & Luis A. Brito. 2017. Vaccine Adjuvants. Vaccine Adjuvants
1
13
.
Daniel F. Hoft, Kathleen Lottenbach, Johannes B. Goll, Heather Hill, Patricia L. Winokur, Shital M. Patel, Rebecca C. Brady, Wilbur H. Chen, Kathryn Edwards, C. Buddy Creech, Sharon E. Frey, Tamara P. Blevins, Rachelle Salomon & Robert B. Belshe. (2016) Priming Vaccination With Influenza Virus H5 Hemagglutinin Antigen Significantly Increases the Duration of T cell Responses Induced by a Heterologous H5 Booster Vaccination. Journal of Infectious Diseases 214:7, pages 1020-1029.
Crossref
Crossref
Rui Liu, Jingbo Wang, Yan Yang, Inamullah Khan, Yue Dong & Naishuo Zhu. (2016) A novel rabies virus lipopeptide provides a better protection by improving the magnitude of DCs activation and T cell responses. Virus Research 221, pages 66-73.
Crossref
Crossref
Milad Lagzian, Mohammad Reza Bassami & Hesam Dehghani. (2016) In vitro responses of chicken macrophage-like monocytes following exposure to pathogenic and non-pathogenic E. coli ghosts loaded with a rational design of conserved genetic materials of influenza and Newcastle disease viruses. Veterinary Immunology and Immunopathology 176, pages 5-17.
Crossref
Crossref
Jasdave S. ChahalOmar F. KhanChristopher L. CooperJustine S. McPartlanJonathan K. TsosieLucas D. TilleySaima M. SidikSebastian Lourido, Robert Langer, Sina BavariHidde L. PloeghDaniel G. Anderson. (2016)
Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and
Toxoplasma gondii
challenges with a single dose
. Proceedings of the National Academy of Sciences 113:29.
Crossref
Crossref
Filipa Lebre, Claire H. Hearnden & Ed C. Lavelle. (2016) Modulation of Immune Responses by Particulate Materials. Advanced Materials 28:27, pages 5525-5541.
Crossref
Crossref
Mehri Habibi, Mohammad Reza Asadi Karam & Saeid Bouzari. (2016)
Transurethral instillation with fusion protein MrpH.FimH induces protective innate immune responses against uropathogenic
Escherichia coli
and
Proteus mirabilis
. APMIS 124:6, pages 444-452.
Crossref
Crossref
Diego Esteban Cargnelutti, María Cristina Salomón, Verónica Celedon, María Fernanda García Bustos, Gastón Morea, Fernando Darío Cuello-Carrión & Eduardo Alberto Scodeller. (2016) Immunization with antigenic extracts of Leishmania associated with Montanide ISA 763 adjuvant induces partial protection in BALB/c mice against Leishmania (Leishmania) amazonensis infection. Journal of Microbiology, Immunology and Infection 49:1, pages 24-32.
Crossref
Crossref
Hyun Jin Kim, Keum‐Young Ahn, Kyung Dong Bae, Jiyun Lee, Sang Jun Sim & Jeewon Lee. (2015) Adjuvant effect of B domain of staphyloccocal protein A displayed on the surface of hepatitis B virus capsid. Biotechnology and Bioengineering 113:2, pages 268-274.
Crossref
Crossref
Ning Wang & Ting Wang. 2016. Vaccine Design. Vaccine Design
635
649
.
Ankur Gupta, Soumen Das, Brian Schanen & Sudipta Seal. (2015) Adjuvants in micro‐ to nanoscale: current state and future direction. WIREs Nanomedicine and Nanobiotechnology 8:1, pages 61-84.
Crossref
Crossref
Christina Monerat Toledo-Machado, Lilian Lacerda Bueno, Daniel Menezes-Souza, Ricardo Andrez Machado-de-Avila, Christophe Nguyen, Claude Granier, Daniella Castanheira Bartholomeu, Carlos Chávez-Olórtegui & Ricardo Toshio Fujiwara. (2015) Use of Phage Display technology in development of canine visceral leishmaniasis vaccine using synthetic peptide trapped in sphingomyelin/cholesterol liposomes. Parasites & Vectors 8:1.
Crossref
Crossref
Arturas KavaliauskisMarianne ArnemoSung-Hyun KimLilia UlanovaMartin SpethBeatriz NovoaSonia DiosØystein EvensenGareth Wyn GriffithsTor Gjøen. (2015)
Use of Poly(I:C) Stabilized with Chitosan As a Vaccine-Adjuvant Against
Viral Hemorrhagic Septicemia Virus
Infection in Zebrafish
. Zebrafish 12:6, pages 421-431.
Crossref
Crossref
Xiaoli Chang & Chang-Qing Xia. (2015) Administration of sulfosuccinimidyl-4-[N-maleimidomethyl] cyclohexane-1-carboxylate conjugated GP10025–33 peptide-coupled spleen cells effectively mounts antigen-specific immune response against mouse melanoma. Biochemical and Biophysical Research Communications 468:1-2, pages 46-52.
Crossref
Crossref
Robert T. Chen, Tom T. Shimabukuro, David B. Martin, Patrick L.F. Zuber, Daniel M. Weibel & Miriam Sturkenboom. (2015) Enhancing Vaccine Safety Capacity Globally. American Journal of Preventive Medicine 49:6, pages S364-S376.
Crossref
Crossref
Robert T. Chen, Tom T. Shimabukuro, David B. Martin, Patrick L.F. Zuber, Daniel M. Weibel & Miriam Sturkenboom. (2015) Enhancing vaccine safety capacity globally: A lifecycle perspective. Vaccine 33, pages D46-D54.
Crossref
Crossref
Daniel O. Villarreal, Nikolaos Svoronos, Megan C. Wise, Devon J. Shedlock, Matthew P. Morrow, Jose R. Conejo-Garcia & David B. Weiner. (2015) Molecular adjuvant IL-33 enhances the potency of a DNA vaccine in a lethal challenge model. Vaccine 33:35, pages 4313-4320.
Crossref
Crossref
Sebastián Di GiacomoValeria QuattrocchiPatricia Zamorano. (2015) Use of Adjuvants to Enhance the Immune Response Induced by a DNA Vaccine Against Bovine Herpesvirus-1. Viral Immunology 28:6, pages 343-346.
Crossref
Crossref
Dulce Bento, Herman F. Staats & Olga Borges. (2015) Effect of particulate adjuvant on the anthrax protective antigen dose required for effective nasal vaccination. Vaccine 33:31, pages 3609-3613.
Crossref
Crossref
D. Bento, H.F. Staats, T. Gonçalves & O. Borges. (2015) Development of a novel adjuvanted nasal vaccine: C48/80 associated with chitosan nanoparticles as a path to enhance mucosal immunity. European Journal of Pharmaceutics and Biopharmaceutics 93, pages 149-164.
Crossref
Crossref
Virgil E.J.C. Schijns, Chrystel Pretto, Laurent Devillers, Denis Pierre, Florence M. Hofman, Thomas C. Chen, Pascal Mespouille, Peter Hantos, Philippe Glorieux, Daniela A. Bota & Apostolos Stathopoulos. (2015) First clinical results of a personalized immunotherapeutic vaccine against recurrent, incompletely resected, treatment-resistant glioblastoma multiforme (GBM) tumors, based on combined allo- and auto-immune tumor reactivity. Vaccine 33:23, pages 2690-2696.
Crossref
Crossref
Jie Ding, Yu Fang & Zou Xiang. (2015) Antigen/IgG immune complex-primed mucosal mast cells mediate antigen-specific activation of co-cultured T cells. Immunology 144:3, pages 387-394.
Crossref
Crossref
Jan Willem van der Laan, Sarah Gould & Jennifer Y. Tanir. (2015) Safety of vaccine adjuvants: Focus on autoimmunity. Vaccine 33:13, pages 1507-1514.
Crossref
Crossref
Li-Ting Cheng, Yao-Chi Chung, Chung-Da Yang, Kuo-Pin Chuang, Guan-Ming Ke & Chun-Yen Chu. 2015. Biological Toxins and Bioterrorism. Biological Toxins and Bioterrorism
449
467
.
Ruchi R. Shah, Luis A. Brito, Derek T. O’Hagan & Mansoor M. Amiji. 2015. Subunit Vaccine Delivery. Subunit Vaccine Delivery
59
76
.
Sheida Shariat, Ali Badiee, Seyed Amir Jalali, Mercedeh Mansourian, Mona Yazdani, Seyed Alireza Mortazavi & Mahmoud Reza Jaafari. (2014) P5 HER2/neu-derived peptide conjugated to liposomes containing MPL adjuvant as an effective prophylactic vaccine formulation for breast cancer. Cancer Letters 355:1, pages 54-60.
Crossref
Crossref
Jiaming Lan, Yao Deng, Hong Chen, Guangwen Lu, Wen Wang, Xiaojuan Guo, Zhuozhuang Lu, George F. Gao & Wenjie Tan. (2014) Tailoring Subunit Vaccine Immunity with Adjuvant Combinations and Delivery Routes Using the Middle East Respiratory Coronavirus (MERS-CoV) Receptor-Binding Domain as an Antigen. PLoS ONE 9:11, pages e112602.
Crossref
Crossref
D. A. Reardon, G. Freeman, C. Wu, E. A. Chiocca, K. W. Wucherpfennig, P. Y. Wen, E. F. Fritsch, W. T. Curry, J. H. Sampson & G. Dranoff. (2014) Immunotherapy advances for glioblastoma. Neuro-Oncology 16:11, pages 1441-1458.
Crossref
Crossref
Theresa Neimert-Andersson, Jonas Binnmyr, Mattias Enoksson, Joakim Langebäck, Louise Zettergren, Anne-Charlotte Hällgren, Henry Franzén, Sara Lind Enoksson, Pierre Lafolie, Alf Lindberg, Nabil Al-Tawil, Mats Andersson, Peter Singer, Hans Grönlund & Guro Gafvelin. (2014) Evaluation of safety and efficacy as an adjuvant for the chitosan-based vaccine delivery vehicle ViscoGel in a single-blind randomised Phase I/IIa clinical trial. Vaccine 32:45, pages 5967-5974.
Crossref
Crossref
Didier Clénet, Frédéric Imbert, Patricia Probeck, Nausheen Rahman & Salvador F. Ausar. (2014) Advanced Kinetic Analysis as a Tool for Formulation Development and Prediction of Vaccine Stability. Journal of Pharmaceutical Sciences 103:10, pages 3055-3064.
Crossref
Crossref
Teresa Merino-Ramos, Ana-Belén Blázquez, Estela Escribano-Romero, Rodrigo Cañas-Arranz, Francisco Sobrino, Juan-Carlos Saiz & Miguel A. Martín-Acebes. (2014) Protection of a Single Dose West Nile Virus Recombinant Subviral Particle Vaccine against Lineage 1 or 2 Strains and Analysis of the Cross-Reactivity with Usutu Virus. PLoS ONE 9:9, pages e108056.
Crossref
Crossref
Ning Wang, Ting Wang, Meiling Zhang, Ruonan Chen, Ruowen Niu & Yihui Deng. (2014) Mannose derivative and lipid A dually decorated cationic liposomes as an effective cold chain free oral mucosal vaccine adjuvant-delivery system. European Journal of Pharmaceutics and Biopharmaceutics 88:1, pages 194-206.
Crossref
Crossref
Huimin Yang, Shuying Han, Danyang Zhao & Guiyun Wang. (2014) Adjuvant effect of polysaccharide from fruits of Physalis alkekengi L. in DNA vaccine against systemic candidiasis. Carbohydrate Polymers 109, pages 77-84.
Crossref
Crossref
Virgil E.J.C. Schijns, Marius Strioga & Stephane Ascarateil. (2014) Oil‐Based Emulsion Vaccine Adjuvants. Current Protocols in Immunology 106:1.
Crossref
Crossref
Ning Wang, Ting Wang, Meiling Zhang, Ruonan Chen & Yihui Deng. (2014) Using procedure of emulsification–lyophilization to form lipid A-incorporating cochleates as an effective oral mucosal vaccine adjuvant-delivery system (VADS). International Journal of Pharmaceutics 468:1-2, pages 39-49.
Crossref
Crossref
C. Arama & M. Troye‐Blomberg. (2014) The path of malaria vaccine development: challenges and perspectives. Journal of Internal Medicine 275:5, pages 456-466.
Crossref
Crossref
Virgil Schijns, Eric Tartour, Jaroslav Michalek, Apostolos Stathopoulos, Neringa T. Dobrovolskienė & Marius M. Strioga. (2014) Immune adjuvants as critical guides directing immunity triggered by therapeutic cancer vaccines. Cytotherapy 16:4, pages 427-439.
Crossref
Crossref
Marybeth Camboni, Chiou-Miin Wang, Carlos Miranda, Jung Hae Yoon, Rui Xu, Deborah Zygmunt, Brian K. Kaspar & Paul T. Martin. (2014) Active and passive immunization strategies based on the SDPM1 peptide demonstrate pre-clinical efficacy in the APPswePSEN1dE9 mouse model for Alzheimer's disease. Neurobiology of Disease 62, pages 31-43.
Crossref
Crossref
Yugang Gao, Xueliang Zhao, Pu Zang, Qun Liu, Gongqing Wei & Lianxue Zhang. (2014)
Generation of the Bovine Viral Diarrhea Virus E0 Protein in Transgenic
Astragalus
and Its Immunogenicity in Sika Deer
. Evidence-Based Complementary and Alternative Medicine 2014, pages 1-7.
Crossref
Crossref
K.A. Schat. 2014. Encyclopedia of Agriculture and Food Systems. Encyclopedia of Agriculture and Food Systems
315
332
.
Virgil E.J.C. Schijns, Saskia van de Zande, Blanca Lupiani & Sanjay M. Reddy. 2014. Avian Immunology. Avian Immunology
345
362
.
Li-Ting Cheng, Yao-Chi Chung, Chung-Da Yang, Kuo-Pin Chuang, Guan-Ming Ke & Chun-Yen Chu. 2013. Toxinology. Toxinology
1
17
.
Guro Gafvelin & Hans Grönlund. 2014. Molecular Vaccines. Molecular Vaccines
623
631
.
Hidekazu Shirota & Dennis M. Klinman. 2014. Cancer Vaccines. Cancer Vaccines
337
344
.
Annina M. Hafner, Blaise Corthésy & Hans P. Merkle. (2013) Particulate formulations for the delivery of poly(I:C) as vaccine adjuvant. Advanced Drug Delivery Reviews 65:10, pages 1386-1399.
Crossref
Crossref
R. Segura-Velázquez, J. Cervantes, E. Acosta, I. Sánchez-Betancourt, N. Villalobos, L.F. Rodarte, M. Restelli, G. Fragoso & E. Sciutto. (2013) Influenza vaccine: Development of a novel intranasal and subcutaneous recombinant adjuvant. Vaccine 31:37, pages 4009-4016.
Crossref
Crossref
T Jake Liang. (2013) Current progress in development of hepatitis C virus vaccines. Nature Medicine 19:7, pages 869-878.
Crossref
Crossref
P. Garrido, A. Prat, I. Crespo, C. Lopez-Ortíz, D. Lumbreras, V. Bertran, S. Gomez & J.J. Abades. (2013) Avances en el desarrollo de vacunas frente a sustancias adictivas (ii). Vacunas antiopiáceos. Otras vacunas. Vacunas 14:3, pages 120-129.
Crossref
Crossref
S. Cerpa-Cruz, P. Paredes-Casillas, E. Landeros Navarro, A. G. Bernard-Medina, G. Martínez-Bonilla & S. Gutiérrez-Ureña. (2013) Adverse events following immunization with vaccines containing adjuvants. Immunologic Research 56:2-3, pages 299-303.
Crossref
Crossref
Christian P. Koch, Anna M. Perna, Max Pillong, Nickolay K. Todoroff, Paul Wrede, Gerd Folkers, Jan A. Hiss & Gisbert Schneider. (2013) Scrutinizing MHC-I Binding Peptides and Their Limits of Variation. PLoS Computational Biology 9:6, pages e1003088.
Crossref
Crossref
Reid A. Roberts, Tammy Shen, Irving C. Allen, Warefta Hasan, Joseph M. DeSimone & Jenny P. Y. Ting. (2013) Analysis of the Murine Immune Response to Pulmonary Delivery of Precisely Fabricated Nano- and Microscale Particles. PLoS ONE 8:4, pages e62115.
Crossref
Crossref
Adolfo García-Sastre & Ignacio Mena. (2013) Novel vaccine strategies against emerging viruses. Current Opinion in Virology 3:2, pages 210-216.
Crossref
Crossref
Ian Teasdale & Oliver Brüggemann. (2013) Polyphosphazenes: Multifunctional, Biodegradable Vehicles for Drug and Gene Delivery. Polymers 5:1, pages 161-187.
Crossref
Crossref
Judy A. Beeler & Maryna C. Eichelberger. (2013) Influenza and respiratory syncytial virus (RSV) vaccines for infants: Safety, immunogenicity, and efficacy. Microbial Pathogenesis 55, pages 9-15.
Crossref
Crossref
Jonathan W. Lockner, Sam On Ho, Karen C. McCague, Su Ming Chiang, Thai Q. Do, Gary Fujii & Kim D. Janda. (2013) Enhancing nicotine vaccine immunogenicity with liposomes. Bioorganic & Medicinal Chemistry Letters 23:4, pages 975-978.
Crossref
Crossref
Claire Hearnden & Ed C. Lavelle. 2013. Cancer Immunotherapy. Cancer Immunotherapy
333
349
.
Adnan Nasir & Anthony Gaspari. 2013. Nanotechnology in Dermatology. Nanotechnology in Dermatology
151
164
.
Ashwini Kumar Giddam, Mehfuz Zaman, Mariusz Skwarczynski & Istvan Toth. (2012) Liposome-based delivery system for vaccine candidates: constructing an effective formulation. Nanomedicine 7:12, pages 1877-1893.
Crossref
Crossref
Xinyuan Chen, Marco Pravetoni, Brijesh Bhayana, Paul R. Pentel & Mei X. Wu. (2012) High immunogenicity of nicotine vaccines obtained by intradermal delivery with safe adjuvants. Vaccine 31:1, pages 159-164.
Crossref
Crossref
Ángel Maquieira, Eva M. Brun, Marta Garcés-García & Rosa Puchades. (2012) Aluminum Oxide Nanoparticles as Carriers and Adjuvants for Eliciting Antibodies from Non-immunogenic Haptens. Analytical Chemistry 84:21, pages 9340-9348.
Crossref
Crossref
Heleen D. de Koning, Anna Simon, Patrick L.J.M. Zeeuwen & Joost Schalkwijk. (2012) Pattern recognition receptors in infectious skin diseases. Microbes and Infection 14:11, pages 881-893.
Crossref
Crossref
Teresa Lambe. (2012) Novel Viral Vectored Vaccines for the Prevention of Influenza. Molecular Medicine 18:8, pages 1153-1160.
Crossref
Crossref
Mirjam Kool, Kaat Fierens & Bart N. Lambrecht. (2012) Alum adjuvant: some of the tricks of the oldest adjuvant. Journal of Medical Microbiology 61:7, pages 927-934.
Crossref
Crossref
Jean-Pierre Amorij, Gideon F.A. Kersten, Vinay Saluja, Wouter F. Tonnis, Wouter L.J. Hinrichs, Bram Slütter, Suzanne M. Bal, Joke A. Bouwstra, Anke Huckriede & Wim Jiskoot. (2012) Towards tailored vaccine delivery: Needs, challenges and perspectives. Journal of Controlled Release 161:2, pages 363-376.
Crossref
Crossref
Peter M. Gray, Gail Forrest, Thomas Wisniewski, Gene Porter, Daniel C. Freed, Julie A. DeMartino, Dennis M. Zaller, Zhiqiang Guo, Joseph Leone, Tong-Ming Fu & Kalpit A. Vora. (2012) Evidence for cyclic diguanylate as a vaccine adjuvant with novel immunostimulatory activities. Cellular Immunology 278:1-2, pages 113-119.
Crossref
Crossref
D.T. O’Hagan, G.S. Ott, E. De Gregorio & A. Seubert. (2012) The mechanism of action of MF59 – An innately attractive adjuvant formulation. Vaccine 30:29, pages 4341-4348.
Crossref
Crossref
Jing Wang, Nancy Tricoche, Lanying Du, Meredith Hunter, Bin Zhan, Gaddam Goud, Elizabeth S. Didier, Jing Liu, Lu Lu, Preston A. Marx, Shibo Jiang & Sara Lustigman. (2012) The Adjuvanticity of an O. volvulus-Derived rOv-ASP-1 Protein in Mice Using Sequential Vaccinations and in Non-Human Primates. PLoS ONE 7:5, pages e37019.
Crossref
Crossref
X Y Shen, F M Orson & T R Kosten. (2011) Vaccines Against Drug Abuse. Clinical Pharmacology & Therapeutics 91:1, pages 60-70.
Crossref
Crossref
V. Quattrocchi, C. Langellotti, J.S. Pappalardo, V. Olivera, S. Di Giacomo, N. van Rooijen, C. Mongini, C. Waldner & P.I. Zamorano. (2011) Role of macrophages in early protective immune responses induced by two vaccines against foot and mouth disease. Antiviral Research 92:2, pages 262-270.
Crossref
Crossref